Author

H. Ogiwara

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

K. Matsushima· 2 shared S. Shichino· 2 shared S. Ueha· 2 shared C.-Y. Chen· 1 shared D. Yang· 1 shared H. Abe· 1 shared H. Aoki· 1 shared H. Shimizu· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. Matsushima

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clonal spreading of tumor-infiltrating T cells underlies the robust antitumor immune responses

H. Aoki, M. Tsunoda, H. Ogiwara, H. Shimizu, H. Abe, T. Abe, S. Shichino, K. Matsushima, S. Ueha

This study shows that polyclonal expansion of tumor-reactive T cells, not oligoclonal expansion, correlates with antitumor effects in response to anti-PD-L1 and anti-CD4 treatments.

bioRxiv · Apr 19, 2022Immunology

Combining an alarmin HMGN1 peptide with PD-L1 blockade facilitates stem-like CD8+ T cell expansion and results in robust antitumor effects

C.-Y. Chen, S. Ueha, Y. Ishiwata, S. Shichino, S. Yokochi, D. Yang, J. J. Oppenheim, H. Ogiwara, S. Deshimaru, Y. Kanno, T. Ogawa, S. Shibayama, K. Matsushima

This study combines an HMGN1 peptide with PD-L1 blockade to expand stem-like CD8+ T cells and enhance antitumor effects in mouse models.

bioRxiv · Dec 15, 2020Immunology